Dual antivascular function of human fibulin‐3 variant, a potential new drug discovery strategy for glioblastoma

Volume: 111, Issue: 3, Pages: 940 - 950
Published: Feb 8, 2020
Abstract
The ECM protein EFEMP1 (fibulin‐3) is associated with all types of solid tumor through its cell context‐dependent dual function. A variant of fibulin‐3 was engineered by truncation and mutation to alleviate its oncogenic function, specifically the proinvasive role in glioblastoma multiforme (GBM) cells at stem‐like state. ZR30 is an in vitro synthesized 39‐kDa protein of human fibulin‐3 variant. It has a therapeutic effect in intracranial...
Paper Details
Title
Dual antivascular function of human fibulin‐3 variant, a potential new drug discovery strategy for glioblastoma
Published Date
Feb 8, 2020
Volume
111
Issue
3
Pages
940 - 950
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.